The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...
BofA raised the firm’s price target on Madrigal Pharmaceuticals (MDGL) to $239 from $154 and keeps an Underperform rating on the shares. The Q4 ...
Three months ago, in its third-quarter report, Madrigal pointed out that it achieved a key goal early by gaining 80% coverage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback